In summary, the current study provides evidence demonstrating UBR5 as a potent metastasis promoter for pancreatic cancer and suggests that UBR5 exerts its metastasis-promoting effect via promoting the ubiquitination and degradation of CAPZA1. This evidence concerns the gene CAPZA1 and familial pancreatic carcinoma.